-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Rhumbline Advisers Trims Stock Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)
Rhumbline Advisers cut its stake in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 0.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 42,007 shares of the specialty pharmaceutical company’s stock after selling 203 shares during the period. Rhumbline […]
Rhumbline Advisers cut its stake in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 0.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 42,007 shares of the specialty pharmaceutical company’s stock after selling 203 shares during the period. Rhumbline […]
